Shire Net Income 2006-2018 | SHPG

Shire annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Shire net income for the quarter ending September 30, 2018 was $0.537B, a 2.47% decline year-over-year.
  • Shire net income for the twelve months ending September 30, 2018 was $4.809B, a 196.21% increase year-over-year.
  • Shire annual net income for 2017 was $4.272B, a 1204.67% increase from 2016.
  • Shire annual net income for 2016 was $0.327B, a 74.88% decline from 2015.
  • Shire annual net income for 2015 was $1.303B, a 61.73% decline from 2014.
Shire Annual Net Income
(Millions of US $)
2017 $4,272
2016 $327
2015 $1,303
2014 $3,406
2013 $665
2012 $745
2011 $865
2010 $588
2009 $492
2008 $156
2007 $-1,452
2006 $278
2005 $-578
Shire Quarterly Net Income
(Millions of US $)
Q3 2018 $537
Q2 2018 $616
Q1 2018 $551
Q4 2017 $3,105
Q3 2017 $551
Q2 2017 $240
Q1 2017 $375
Q4 2016 $457
Q3 2016 $-387
Q2 2016 $-162
Q1 2016 $419
Q4 2015 $281
Q3 2015 $453
Q2 2015 $160
Q1 2015 $410
Q4 2014 $2,172
Q3 2014 $480
Q2 2014 $523
Q1 2014 $230
Q4 2013 $64
Q3 2013 $278
Q2 2013 $258
Q1 2013 $65
Q4 2012 $42
Q3 2012 $227
Q2 2012 $238
Q1 2012 $238
Q4 2011 $255
Q3 2011 $193
Q2 2011 $206
Q1 2011 $211
Q4 2010 $165
Q3 2010 $96
Q2 2010 $161
Q1 2010 $166
Q4 2009 $174
Q3 2009 $60
Q2 2009 $44
Q1 2009 $214
Q4 2008 $141
Q3 2008 $-35
Q2 2008 $-79
Q1 2008 $129
Q4 2007 $212
Q3 2007 $35
Q2 2007 $-1,811
Q1 2007 $113
Q4 2006 $69
Q3 2006 $87
Q2 2006 $61
Q1 2006 $61
Q4 2005 $-73
Q3 2005 $-631
Q2 2005 $110
Q1 2005 $15
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $53.371B $15.161B
Shire Pharmaceuticals Group plc is a specialty pharmaceutical company focused primarily on two therapeutic areas: central nervous system disorders and metabolic bone diseases. (press release)
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $44.331B 30.35
Grifols (GRFS) Spain $14.524B 17.73
Tilray (TLRY) United States $10.290B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.614B 12.36
Neurocrine Biosciences (NBIX) United States $8.160B 1799.60
Ionis Pharmaceuticals (IONS) United States $7.393B 0.00
Nektar Therapeutics (NKTR) United States $6.617B 9.49
Catalent (CTLT) United States $5.726B 24.02
Impax Laboratories (AMRX) United States $5.526B 29.38
Sage Therapeutics (SAGE) United States $5.355B 0.00
United Therapeutics (UTHR) United States $5.295B 8.66
Loxo Oncology (LOXO) United States $4.792B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.937B 14.58
FibroGen (FGEN) United States $3.437B 0.00
USANA Health Sciences (USNA) United States $2.884B 24.55
Endo (ENDP) Ireland $2.847B 4.36
Xencor (XNCR) United States $2.239B 0.00
Heron Therapeutics (HRTX) United States $2.084B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.000B 0.00
Aerie Pharmaceuticals (AERI) United States $1.949B 0.00
Endocyte (ECYT) United States $1.943B 0.00
TESARO (TSRO) United States $1.924B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.924B 260.00
Ironwood Pharmaceuticals (IRWD) United States $1.846B 0.00
PTC Therapeutics (PTCT) United States $1.711B 0.00
Zogenix (ZGNX) United States $1.710B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.573B 19.24
Corcept Therapeutics (CORT) United States $1.503B 22.07
Theravance Biopharma (TBPH) Cayman Islands $1.454B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.413B 0.00
Portola Pharmaceuticals (PTLA) United States $1.329B 0.00
Tricida (TCDA) United States $1.318B 0.00
Esperion Therapeutics (ESPR) United States $1.300B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.179B 0.00
TherapeuticsMD (TXMD) United States $1.158B 0.00
ImmunoGen (IMGN) United States $0.892B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.863B 0.00
Radius Health (RDUS) United States $0.761B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.690B 0.00
Karyopharm Therapeutics (KPTI) United States $0.678B 0.00
Flexion Therapeutics (FLXN) United States $0.638B 0.00
Collegium Pharmaceutical (COLL) United States $0.578B 0.00
GlycoMimetics (GLYC) United States $0.515B 0.00
ChemoCentryx (CCXI) United States $0.514B 40.68
Rigel Pharmaceuticals (RIGL) United States $0.477B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.468B 0.00
Akebia Therapeutics (AKBA) United States $0.455B 0.00
Siga Technologies (SIGA) United States $0.448B 0.00
Odonate Therapeutics (ODT) United States $0.443B 0.00
Xeris Pharmaceuticals (XERS) United States $0.439B 0.00
Dova Pharmaceuticals (DOVA) United States $0.437B 0.00
ArQule (ARQL) United States $0.436B 0.00
OptiNose (OPTN) United States $0.425B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.423B 24.96
Aquestive Therapeutics (AQST) United States $0.421B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.412B 0.00
Dermira (DERM) United States $0.409B 0.00
Forty Seven (FTSV) United States $0.404B 0.00
CASI Pharmaceuticals (CASI) United States $0.391B 0.00
Zafgen (ZFGN) United States $0.364B 0.00
Aclaris Therapeutics (ACRS) United States $0.361B 0.00
Depomed (ASRT) United States $0.351B 13.07
Corbus Pharmaceuticals Holdings (CRBP) United States $0.347B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.346B 0.00
Mast Therapeutics (SVRA) United States $0.330B 0.00
Tapimmune (MRKR) United States $0.329B 0.00
Minerva Neurosciences (NERV) United States $0.327B 0.00
KalVista Pharmaceuticals (KALV) United States $0.324B 0.00
Aratana Therapeutics (PETX) United States $0.319B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.317B 0.00
Concert Pharmaceuticals (CNCE) United States $0.313B 0.00
Translate Bio (TBIO) United States $0.307B 0.00
Majesco Entertainment (PTE) United States $0.269B 0.00
Affimed (AFMD) Germany $0.266B 0.00
IMV INC (IMV) Canada $0.254B 0.00
Opexa Therapeutics (ACER) United States $0.249B 0.00
Lannett Co Inc (LCI) United States $0.233B 2.03
Tyme Technologies (TYME) United States $0.232B 0.00
Aldeyra Therapeutics (ALDX) United States $0.231B 0.00
Ocular Therapeutix (OCUL) United States $0.219B 0.00
MEI Pharma (MEIP) United States $0.216B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.212B 0.00
Galectin Therapeutics (GALT) United States $0.208B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.205B 0.00
Calithera Biosciences (CALA) United States $0.197B 0.00
Neon Therapeutics (NTGN) United States $0.197B 0.00
ElectroCore (ECOR) United States $0.192B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.186B 0.00
Ardelyx (ARDX) United States $0.186B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.181B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.181B 0.00
Nature's Sunshine Products (NATR) United States $0.177B 0.00
Molecular Templates (MTEM) United States $0.173B 0.00
Redhill Biopharma (RDHL) Israel $0.168B 0.00
ContraFect (CFRX) United States $0.166B 0.00
MediWound (MDWD) Israel $0.162B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.151B 0.00
DURECT (DRRX) United States $0.144B 0.00
Jounce Therapeutics (JNCE) United States $0.144B 0.00
Recro Pharma (REPH) United States $0.141B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.140B 0.00
Melinta Therapeutics (MLNT) United States $0.139B 0.00
Champions Oncology (CSBR) United States $0.139B 0.00
Adherex Technologies (FENC) United States $0.137B 0.00
ProNAi Therapeutics (SRRA) Canada $0.127B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.123B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.122B 0.00
Cardiome Pharma (CORV) Canada $0.113B 0.00
Rafael Holdings (RFL) United States $0.109B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.099B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 0.00
CTI BioPharma (CTIC) United States $0.098B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.097B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.088B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.082B 0.00
Iterum Therapeutics (ITRM) Ireland $0.081B 0.00
Infinity Pharmaceuticals (INFI) United States $0.080B 0.00
Otonomy (OTIC) United States $0.076B 0.00
Achaogen (AKAO) United States $0.076B 0.00
Nivalis Therapeutics (ALPN) United States $0.073B 0.00
BioLineRx (BLRX) Israel $0.071B 0.00
Natural Alternatives (NAII) United States $0.070B 6.85
KemPharm (KMPH) United States $0.067B 0.00
Immune Design (IMDZ) United States $0.066B 0.00
Novan (NOVN) United States $0.063B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.062B 0.00
Forward Pharma (FWP) Denmark $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.059B 36.93
Avenue Therapeutics (ATXI) United States $0.059B 0.00
Neos Therapeutics (NEOS) United States $0.058B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.053B 0.00
Genocea Biosciences (GNCA) United States $0.050B 0.00
Capnia (SLNO) United States $0.045B 0.00
Mannatechorporated (MTEX) United States $0.043B 0.00
Trillium Therapeutics (TRIL) Canada $0.043B 0.00
Heat Biologics (HTBX) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.038B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.90
Lipocine (LPCN) United States $0.031B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
Biomerica (BMRA) United States $0.027B 0.00
IsoRay (ISR) United States $0.026B 0.00
NanoViricides (NNVC) United States $0.025B 0.00
Onconova Therapeutics (ONTX) United States $0.025B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
HANCOCK JAFFE (HJLI) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.020B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.019B 0.00
Aviragen Therapeutics (VXRT) United States $0.019B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.019B 6.75
ESSA Pharma (EPIX) Canada $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
Shineco (TYHT) China $0.016B 1.60
Aradigm (ARDM) United States $0.015B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.012B 0.00
Skyline Medical (AIPT) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
PharmAthene (ALT) United States $0.006B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
RXi Pharmaceuticals (RXII) United States $0.001B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00